EndoTODAY | EndoATLAS | OPD

Parasite | Eso | Sto | Cancer | ESD

Boxim | DEX | Sono | Schedule

Home | Recent | Blog | Links

EndoTODAY ³»½Ã°æ ±³½Ç


[ºÐ¼±Ãæ. Strongyloides stercoralis - HyperinfectionÀº ¿Ö ¹«¼·½À´Ï±î?]

ºÐ¼±Ãæ(Strongyloides stercoralis)Àº Á¦°¡ °¡Àå ¹«¼­¿öÇÏ´Â ±â»ýÃæÀÔ´Ï´Ù. ȯÀÚ°¡ Á×À» ¼ö Àֱ⠶§¹®ÀÔ´Ï´Ù. Hyperinfection syndromeÀ̶ó°í ÇÕ´Ï´Ù.


1. ºÐ¼±ÃæÀ̶õ?

ºÐ¼±Ãæ(Strongyloides stercoralis)Àº ƯÀÌÇÑ ¼±ÃæÀÔ´Ï´Ù. (1) ÀÎü°¨¿° ¼±Ãæ Áß ±× Å©±â°¡ °¡Àå ÀÛ½À´Ï´Ù. mm ´ÜÀ§ ÀÌÇÏÀÔ´Ï´Ù. (2) ÀÚÀ¯»ýÈ°¼¼´ë (free-living generation)¸¦ °¡Áý´Ï´Ù. Áï Èë¿¡¼­ ½º½º·Îµµ Àß »ì¾Æ°©´Ï´Ù. (3) ÇǺθ¦ ÅëÇØ Ä§ÀÔÇÕ´Ï´Ù. (4) AutoinfectionÀÌ °¡´ÉÇÕ´Ï´Ù. ´ëºÎºÐÀÇ ¼±ÃæÀº Ãæ¶õ Çϳª¸¦ ¸ÔÀ¸¸é ¸ö ¼Ó¿¡ ÇÑ ¸¶¸®ÀÇ ±â»ýÃæÀÌ »ý±é´Ï´Ù. ±×·¯³ª ºÐ¼±ÃæÀº ÀÎüÀÇ ¸é¿ª·ÂÀÌ ¾àÇϸé ÀÚ°¡°¨¿°À» ÅëÇÏ¿© ¹«ÇÑÁõ½ÄÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â»ýÃæÀÌ ¹«ÇÑÁõ½ÄÇÏ´Ï È¯ÀÚ°¡ ÁװԵǴ °ÍÀÔ´Ï´Ù. Autoinfection ¶§¹®¿¡ ȯÀÚ°¡ Á×À» ¼ö ÀÖ´Â ¶Ç ´Ù¸¥ ±â»ýÃæÀº Àå¸ð¼¼¼±Ãæ (Capillaria philippinensis)ÀÔ´Ï´Ù.

°¡Àå Áß¿äÇÑ Æ¯Â¡Àº Å©±â°¡ ÀÛ´Ù´Â °ÍÀÔ´Ï´Ù. °ÅÀÇ ´«¿¡ º¸ÀÌÁö ¾Ê½À´Ï´Ù. 0.5-2mm Å©±âÀ̸鼭 ¸Å¿ì °¡´Ã±â ¶§¹®ÀÔ´Ï´Ù. ȸÃæÀº 30cmÀÌ°í ¿äÃæÀ̳ª ÆíÃæÀº 2-4cm ¶ó´Â °ÍÀ» »ý°¢ÇØ º¸¸é ¾ó¸¶³ª ÀÛÀºÁö ¾Ë ¼ö ÀÖ½À´Ï´Ù. ¾Æ·¡ ±×¸²¿¡¼­ ±× Å©±â¸¦ ºñ±³ÇØ º¸½Ê½Ã¿ä. ºÐ¼±ÃæÀÌ ´«¿¡ º¸À̱⳪ Çմϱî? µû¶ó¼­ Å©±â·Î ´ë°­ °¨º°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

ºÐ¼±Ãæ°ú ´Ù¸¥ ¼±Ãæ°úÀÇ »ó´ëÀûÀÎ Å©±â ºñ±³

ºÐ¼±Ãæ Çö¹Ì°æ ¼Ò°ß


2. ºÐ¼±ÃæÁõÀÇ ÀÓ»ó Áõ»ó

º¸Åë °¨¿°µÇ´õ¶óµµ Áõ»óÀÌ ¾ø´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. µå¹°°Ô À§Àå°ü ±Ë¾çÀ» ÀÏÀ¸Å³ ¼ö ÀÖ½À´Ï´Ù.

A 67-year-old man with a history of kidney transplantation for renal cell carcinoma presented for esophagogastroduodenoscopy for epigastric pain. The pain was described as a burning sensation, occurring four times a day. In a review of systems, the patient also endorsed intermittent nausea and vomiting, loss of appetite, and a five-pound weight loss over 3 weeks. Of note, he was on dual immunosuppressive therapy (mycophenolate and tacrolimus) as well as a recent prednisone taper due to suspicion of mild transplant rejection. Upper endoscopy showed antral nodules, erythema, and diffuse superficial erosions (a). The duodenal bulb also appeared diffusely erythematous with superficial erosions (b). Histologic examination was negative for Helicobacter pylori or cytomegalovirus but showed numerous larvae in the duodenal crypts and gastric pits consistent with strongyloidiasis (c). The patient was put on 12 mg of Ivermectin by mouth daily for two weeks. When he was seen by his primary-care physician one month after hospital discharge, the epigastric pain had resolved. Stool studies detected no remaining strongyloides. Given the resolution of his symptoms and negative stool studies, repeat endoscopy was not performed. (Am J Gastroenterol 2016)

Researchers describe a nearly missed case of Strongyloides infection in the April issue of Gastroenterology, had it not been for analysis of duodenal biopsies. Douglas Grunwald et al describe the case of a 74-year-old Jamaican-born woman with a 3-month history of dyspepsia, nausea, bloating, early satiety, and weight loss of 40 lbs. In the past, she had been infected with Helicobacter pylori and Strongyloides, both of which were treated; she also had a history of acid reflux, diabetes, and hypertension. Her medications included metformin, simvastatin, and losartan. An abdominal computed tomography (CT) scan showed signs of endometrial cancer. She subsequently had an uncomplicated abdominal hysterectomy. However, she continued to have nausea, anorexia, and failure to thrive. On readmission to the hospital 15 days after surgery, a CT scan showed small bowel hyperenhancement, edema, and anasarca. Tests of stool for Strongyloides ova, parasite, and antibodies all gave negative results. The physicians performed an esophagogastroduodenoscopy and found large, geographic duodenal ulcers with brownish discoloration of the mucosa (arrows in figure A). She had not used nonsteroidal anti-inflammatory drugs and tested negative for H pylori. Duodenal biopsies revealed parasitic forms consistent with Strongyloides species (figure B). Strongyloides is a soil-transmitted helminth - its primary mode of infection is through contact with soil that is contaminated with free-living larvae. When the larvae come in contact with skin, they penetrate it and migrate through the body, eventually finding their way to the small intestine, where they burrow and lay their eggs. Unlike other soil-transmitted helminths like hookworm or whipworm, whose eggs do not hatch until they are in the environment, the eggs of Strongyloides hatch into larvae in the intestine. Most of these larvae are excreted in the stool, but some of the larvae molt and immediately re-infect the host either by burrowing into the intestinal wall or by penetrating the perianal skin. Gastrointestinal manifestations of Strongyloides infection include nausea, vomiting, anorexia, abdominal pain, and protein-losing enteropathy. Patients are usually treated with anti-helminth drugs (eg, ivermectin, albendazole). The researchers say that they did not have positive results from stool studies or ELISAs for Strongyloidesserum antibodies because the sensitivity of repeated stool evaluation is around 50%, and sensitivity of the ELISA test is 65%-90%. Furthermore, the antibodies are often not detected in immune-compromised patients. Grunwald et al state that the best way to detect this infection is by histopathology analysis of duodenal biopsies. The endoscopic features of duodenal Strongyloides infection are broad and include edema, brown discoloration of the mucosa, erythema, subepithelial hemorrhages, and megaduodenum. These features are nonspecific and are also seen in patients with ischemic ulcers, users of nonsteroidal anti-inflammatory drugs, or patients with cancer or H pylori infection. Due to the patient¡¯s history of previous Strongyloides infection, the authors began treating her with ivermectin before pathologic confirmation of the parasite. Grunwald et al say that the severity of the patient¡¯s illness was likely precipitated by her recent malignancy and a new diagnosis of human T-lymphotropic virus (HTLV-1) infection, which is endemic to the Caribbean and commonly observedin combination with Strongyloides. The authors propose that HTLV-1 disrupts the ability of T cells to detect and eliminate Strongyloides. The patient was treated successfully with an extended regimen of ivermectin and nutritional support. Four months after treatment, her weight was stable, her albumin level increased, and a repeat esophagogastroduodenoscopy showed normal duodenal mucosa.

2013³â 6¿ù 11ÀÏ ³»½Ã°æÇÐȸ Áý´ãȸ¿¡¼­ ½ÊÀÌÁöÀå SMT ÇüÅ·Π³ªÅ¸³­ ºÐ¼±ÃæÁõ¿¡ ´ëÇÑ ¹ßÇ¥°¡ ÀÖ¾ú½À´Ï´Ù (¼º¸ðº´¿ø Áõ·Ê). SMT·Î ¹ßÇöÇÑ ºÐ¼±ÃæÁõÀº óÀ½ º¸¾Ò½À´Ï´Ù.

2017³â IDEN¿¡¼­ ´Ù½Ã ¼Ò°³µÇ¾ú½À´Ï´Ù.


3. Hyperinfection syndrome

½ºÅ×·ÎÀ̵峪 Ç×¾ÏÁ¦¿¡ ÀÇÇÏ¿© ¸é¿ª·ÂÀÌ ¶³¾îÁö¸é ¹«ÇÑ ÀÚ°¡Áõ½ÄÇÏ¿© hyperinfection syndromeÀÌ ¹ß»ýÇÕ´Ï´Ù. Àü½Å¿¡ ºÐ¼±Ãæ À¯ÃæÀÌ ÆÛÁö´Â hyperinfection syndromeÀÇ »ç¸Á·üÀº 100%ÀÔ´Ï´Ù. ±×·¡¼­ ¹«¼·½À´Ï´Ù.

Ç×¾ÏÄ¡·á Áß ¹ß»ýÇÑ ºÐ¼±Ãæ¿¡ ÀÇÇÑ ÆóÆ÷ÃâÇ÷

½ºÅ×·ÎÀÌµå »ç¿ë°ú °ü·ÃµÈ hyperinfection syndrome


4. ºÐ¼±ÃæÁõÀÇ Áø´Ü

ºÐ¼±ÃæÁõÀº Ãæ¶õÀ¸·Î Áø´ÜÇÒ ¼ö ¾ø½À´Ï´Ù. ´ëº¯, ½ÊÀÌÁöÀ庮, °¡·¡¿¡¼­ À¯ÃæÀ» °üÂûÇÏ¿© Áø´ÜÇÕ´Ï´Ù.


2016³â 1¿ù American Journal of Gastroenterology¿¡ ¼³»ç, pseudomelanosis duodeni·Î ¹ßÇöÇÑ ºÐ¼±ÃæÁõ Áõ·Ê ÀÓ»óÈ­º¸°¡ ½Ç·È½À´Ï´Ù. ´ëº¯ °Ë»ç¿¡¼­ ºÐ¼±ÃæÀÌ È®ÀÎµÈ µå¹® °æ¿ìÀÔ´Ï´Ù. ¸»·Î¸¸ µé¾úÁö ´ëº¯¿¡¼­ ºÐ¼±ÃæÀÌ ³ª¿Â ÀÓ»óÈ­º¸´Â óÀ½ º¸¾Ò½À´Ï´Ù. Á¶Á÷°Ë»ç·Î Áø´ÜÇÑ °æ¿ì°¡ ´õ ¸¹¾Ò°Åµç¿ä.


5. ºÐ¼±ÃæÁõÀÇ Ä¡·á

Ä¡·áÈ¿°ú´Â thiabendazoleÀÌ °¡Àå ÁÁÀºµ¥ ºÎÀÛ¿ëÀÌ ¸¹´Ù´Â ´ÜÁ¡ÀÌ ÀÖ½À´Ï´Ù. ÇöÀçÀÇ treatment of choice´Â ivermectinÀ¸·Î Á¤¸®µÈ °Í °°½À´Ï´Ù. 95% ÀÌ»ó È¿°ú°¡ ÀÖÀ¸¸é¼­ ºÎÀÛ¿ëÀÇ ºóµµ´Â ÈξÀ ³·½À´Ï´Ù.

¿©·¯ºÐÀÌ ¸¹ÀÌ º¸½Ã´Â emedicine.medscape.com¿¡´Â "Ivermectin (Stromectol). Binds to glutamate-gated chloride ion channels in invertebrate nerve and muscle cells. Increased permeability of the cell membrane occurs with hyperpolarization, resulting in paralysis and death of the parasite. Effective against adult intestinal strongyloides. Cure rate is 97% with 2-day course. Case reports have been made of successful SC injection of ivermectin in patients unable to achieve adequate serum drug levels after oral administration"¶ó°í µÇ¾î ÀÖ½À´Ï´Ù.

º» º´¿ø ¾àÁ¦°ú¿¡ ¹®ÀÇÇÑ ¹Ù ´ÙÀ½°ú °°Àº ´äº¯À» ¹Þ¾Ò½À´Ï´Ù. 'Thiabendazole, ivermectinÀº Èñ±ÍÀǾàÇ°¼¾ÅÍ¿¡¼­´Â °ø±ÞµÇ°í ÀÖÁö ¾Ê½À´Ï´Ù. ÇöÀç (2011-4-3) ±¹¸³ÀÇ·á¿ø¿¡¼­ ¾àÀ» ±¸ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±¹¸³ÀÇ·á¿ø¿¡¼­´Â 'ÇØ¿ÜÀ¯ÀÔÀü¿°º´°ü¸®±ÔÁ¤'¿¡ µû¶ó Áúº´°ü¸®º»ºÎ¿¡¼­ ±¸¸Å ¹× °ø±ÞÇÏ°í ÀÖ´Â ±¹³» ºñÃà¿ë ÇØ¿ÜÀ¯ÀÔÀü¿°º´Ä¡·á¾à ÁöÁ¤¸ñ·ÏÀ» Åõ¾àÇÏ°í ÀÖ½À´Ï´Ù. ±¹¸³ÀÇ·á¿ø ¾àÁ¦°ú 2260-7389'


[References]

1) ¿£µµÅõµ¥ÀÌ ±â»ýÃæÇÐ

2) Spectrum of chronic small bowel diarrhea with malabsorption in Indian subcontinent: is the trend really changing? Àεµ¿¡¼­´Â »ý°¢º¸´Ù ±â»ýÃæÁõÀÌ ¾ÆÁ÷µµ Áß¿äÇÑ ºÎºÐÀ» Â÷ÁöÇÏ°í ÀÖ¾ú½À´Ï´Ù. ºÐ¼±Ãæ (Strongyloides stercoralis)µµ Èï¹Ì·Ó½À´Ï´Ù.

3) µå¹°Áö¸¸ Áß¿äÇÑ °¨¿°¼º À§¿°µé (À̿ϽÄ). ³»½Ã°æÇÐȸ ¼¼¹Ì³ª



© ÀÏ¿ø³»½Ã°æ±³½Ç ¹Ù¸¥³»½Ã°æ¿¬±¸¼Ò ÀÌÁØÇà. EndoTODAY Endoscopy Learning Center. Lee Jun Haeng.